NDANASALSPRAY
Approved
Dec 2025
Lifecycle
Launch
Competitive Pressure
0/100
Mechanism of Action
L-type calcium influx inhibitor (slow channel blocker or calcium ion antagonist). Etripamil exerts its pharmacologic effect by modulating the influx of ionic calcium across the cell membrane of the AV nodal cells as well as arterial smooth muscles and contractile myocardial cells. By interrupting…
Loss of Exclusivity
LOE Date
Jul 15, 2042
199 months away
Patent Expiry
Jul 15, 2042
Exclusivity Expiry
Dec 12, 2030